EUVIMEDEUVIMED entdecken
Crossref

Prevalence and outcomes of pulmonary embolism with sickle cell disease: Analysis of the Nationwide Inpatient Sample, 2016–2020

Nosakhare Paul Ilerhunmwuwa, Olayemi Adeniran, Lawrence Inyang, Mustafa Wasifuddin, Narek Hakobyan, Jamal Christopher Perry, Abul Hasan Shadali Abdul Khader, Muhammad Tahir, Jen Chin Wang iD

European Journal of Haematology · 2023

DOI: 10.1111/ejh.14025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Haematology, 2023. Verfasst von Nosakhare Paul Ilerhunmwuwa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Department, One Brooklyn Health/Brookdale University Hospital and Medical Center, Brooklyn, New York, USA. Hauptthemen laut MEDLINE: Pulmonary Embolism, Anemia, Sickle Cell. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The outcomes of pulmonary embolism (PE) in sickle cell disease (SCD) are poorly established in the literature. This study examined the prevalence and outcomes of patients with PE and SCD.

Methods

The National Inpatient Sample was used to identify patients' data with a diagnosis of PE and SCD in the United States from 2016 to 2020 using the International Classification of Disease, 10th Revision codes. Logistic regression was used to compare outcomes between those with and without SCD.

Results

Of the 405 020 patients with PE, 1504 (0.4%) had SCD, and 403 516 (99.6%) did not have SCD. The prevalence of PE with SCD was stable. Patients in the SCD group were more likely to be female (59.5% vs. 50.6%; p < .0001), Black (91.7% vs. 54.4%; p < .0001), with a lower rate of comorbidities. The SCD group had higher in‐hospital mortality (odds ratio [OR] = 1.41, 95% confidence interval [CI]:1.08–1.84; p = .012) but lower catheter‐directed thrombolysis (OR = 0.23, 95% CI: 0.08–0.64; p = .005), mechanical thrombectomy (OR = 0.59, 95% CI: 0.41–0.64; p < .0029), and inferior vena cava filter placement (OR = 0.47, 95% CI: 0.33–0.66; p < .001).

Conclusion

In‐hospital mortality remains high in PE with SCD. A proactive approach, including maintaining a high index of suspicion for PE, is needed to reduce in‐hospital mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary EmbolismAnemia, Sickle CellHumansFemaleUnited StatesMaleInpatientsPrevalenceHospital MortalityRetrospective Studies

Stichwörter der Autor:innen

outcomespulmonary embolismsickle cell disease

Autor:innen und Institutionen

  • Internal Medicine Department, One Brooklyn Health/Brookdale University Hospital and Medical Center, Brooklyn, New York, USA.
  • Government Kilpauk Medical College, Chennai, Tamil Nadu, India.
  • Department of Hematology and Oncology, One Brooklyn Health/Brookdale University Hospital and Medical Center, Brooklyn, New York, USA.

ORCID-Profile: Jen Chin Wang

Zitieren

APA

Ilerhunmwuwa, N. P., Adeniran, O., Inyang, L., Wasifuddin, M., Hakobyan, N., Perry, J. C., Abdul Khader, A. H. S., Tahir, M., & Wang, J. C. (2023). Prevalence and outcomes of pulmonary embolism with sickle cell disease: Analysis of the Nationwide Inpatient Sample, 2016–2020. European Journal of Haematology. https://doi.org/10.1111/ejh.14025

Vancouver

Ilerhunmwuwa NP, Adeniran O, Inyang L, Wasifuddin M, Hakobyan N, Perry JC, et al. Prevalence and outcomes of pulmonary embolism with sickle cell disease: Analysis of the Nationwide Inpatient Sample, 2016–2020. European Journal of Haematology. 2023. doi:10.1111/ejh.14025

BibTeX
@article{Ilerhunmwuwa2023,
  author = {Ilerhunmwuwa, Nosakhare Paul and Adeniran, Olayemi and Inyang, Lawrence and Wasifuddin, Mustafa and Hakobyan, Narek and Perry, Jamal Christopher and Abdul Khader, Abul Hasan Shadali and Tahir, Muhammad and Wang, Jen Chin},
  title = {Prevalence and outcomes of pulmonary embolism with sickle cell disease: Analysis of the Nationwide Inpatient Sample, 2016–2020},
  journal = {European Journal of Haematology},
  year = {2023},
  doi = {10.1111/ejh.14025}
}
Kostenlos starten →